Meet the Staff
Rhoda Z. Arzoomanian, BSN, RN, MSM, Associate Director, Clinical Research, Yale Center for Clinical Investigation and the Yale Cancer Center
A nationally recognized expert in cancer clinical research, clinical trials databases, and the management of an NCI-designated cancer center, Arzoomanian has over 25 years of clinical research experience. She has held the position of associate director of administration at the University of Wisconsin Carbone Comprehensive Cancer Center (UWCCC) since 2010. She began her career at the UWCCC as a research nurse in the Phase I Clinical Research Program and rose to Phase I program manager and assistant director for clinical research before assuming her most recent position. She was responsible for overseeing the UWCCC’s operational activities, including administrative, finance, research administration, clinical research, clinical informatics and strategic development.
At Yale, her role will encompass clinical research across the medical campus, including Yale Cancer Center. She will oversee clinical research regulatory units, developing results-oriented strategies for these areas, as well as testing and verifying compliance and good clinical practices. Her experience over the past 15 years working on three NIH Cancer Center Support Grants at the UWCCC, most recently overseeing the entire renewal and site visit in 2012, will be invaluable in her role at Yale, as will her ability to bring people from diverse backgrounds together.
“We are thrilled to have Rhoda join our team and help us expand Yale’s clinical research program,” said Robert Sherwin, M.D., director of YCCI. “Her experience in cancer clinical research will translate across our entire research enterprise as we seek to fortify and grow clinical trials at Yale.”
YCCI has a history of collaboration with Yale Cancer Center, as evidenced by their identification of shared goals and resources to solidify a mutually beneficial partnership. The two centers jointly support the Yale Center for Analytical Sciences and several research cores; have worked together to implement OnCore; and merged components of the infrastructure to support clinical and translational research, including financial administration, billing, IND support and development, quality assurance, and training. Arzoomanian’s familiarity with cancer clinical research and her role in overseeing clinical trials across the entire institution help cement the relationship between YCCI and Yale Cancer Center, which has benefitted clinical research as a whole at Yale.
“We are delighted to welcome Rhoda to Yale Cancer Center. She will bring a bolt of energy to our efforts to build a rigorous infrastructure to support our expanding portfolio of clinical research,” said Thomas Lynch, Jr., M.D., director of Yale Cancer Center.
At the UWCCC, Arzoomanian worked with both Epic and OnCore, an approach similar to Yale’s enterprise-wide adoption of these systems as the foundation of its it platform. She was a subject matter expert and worked on the design of the financial billing module prior to and during the OnCore implementation at the UWCCC, which was the first site to implement this system. The UWCCC is also a Clinical and Translational Science Award (CTSA) site, and she has worked with Yale colleagues as the two institutions have collaborated and shared lessons learned over the past several years.
“I am absolutely thrilled to be joining Yale,” said Arzoomanian. “I’m excited to be part of this amazing team and I hope my past experience can bring a fresh new perspective.”
Alyssa K. Gateman, MPH CCRP - Director, Quality Assurance & Training, Yale Center for Clinical Investigation
In an effort to ensure the high quality of clinical research at Yale, YCCI is expanding its QA staff with the addition of Alyssa Gateman, M.P.H., CCRP, who will join Yale on July 1. She will be working with Susan Anderson, R.N., B.S.N., M.F.A., YCCI associate director for quality assurance and training, to support quality initiatives for clinical research across the medical campus.
Gateman is a recognized and respected QA expert who brings a wealth of experience to Yale’s QA team. She joins Yale from the Dana-Farber/Harvard Cancer Center (DF/HCC), where she most recently served as director of the Quality Assurance Office for Clinical Trials (QACT). Throughout her 14-year tenure at Dana-Farber, she provided oversight of all protocol registration, data collection design of investigator-initiated clinical trials, and management of the internal auditing program. As director of the QACT, she provided leadership and management for the Data and Safety Monitoring Committee, Multi-Center Review Committee, Audit Committee, Clinical Investigations Leadership Committee, and Clinical Operations Committee (responsible for development of DF/HCC policies and procedures). She was directly involved with the Dana-Farber/Harvard Cancer Center’s participation in the NCI’s Cancer Center Support Grant as well as in a pilot initiative for the Clinical Trial Reporting Program (CTRP).